Literature DB >> 10620191

Studies of renal injury III: lipid-induced nephropathy in type II diabetes.

J H Dominguez1, N Tang, W Xu, A P Evan, A N Siakotos, R Agarwal, J Walsh, M Deeg, J H Pratt, K L March, V M Monnier, M F Weiss, J W Baynes, R Peterson.   

Abstract

UNLABELLED: Studies of renal injury III: Lipid-induced nephropathy in type II diabetes.
BACKGROUND: Nephrotoxicity from elevated circulating lipids occurs in experimental and clinical situations. We tested the hypothesis that lipid-induced nephropathy causes advanced renal failure in rats with type II diabetes and dyslipidemia.
METHODS: First generation (F1) hybrid rats derived from the spontaneous hypertensive heart failure rat (SHHF/Gmi-fa) and the LA/NIH-corpulent rat (LA/N-fa) were studied for 41 weeks while being on specific diets. Group 1 (14 rats) ingested 11.5% protein, 47.9% fat, and 40.6% carbohydrate. Group 2 (8 rats) ingested 26.9% protein, 16.7% animal fat, and 56.4% carbohydrate, and group 3 (20 rats) ingested 20.2% protein, 40.4% soy and coconut oil, and 39.4% carbohydrate.
RESULTS: Hyperglycemia was more severe in rat groups 1 and 2 than in group 3. In contrast, circulating cholesterol and hydroperoxide levels were highest in group 3, intermediate in group 2, and lowest in group 1. Group 3 had severe renal failure secondary to glomerulosclerosis and tubulointerstitial disease, with striking deposition of the lipid peroxidation stress biomarker 4-hydroxynonenal in glomeruli and renal microvessels. Moreover, in group 3, increased arterial wall thickness also connoted vascular injury. In contrast, the glycoxidation stress biomarkers pentosidine and carboxymethyl-lysine were preferentially localized to renal tubules of hyperglycemic rats in groups 1 and 2 and did not segregate with the most severe renal injury. Glomerular and interstitial fibrosis was accompanied by proportional increases in renal transforming growth factor-beta1 levels, which were threefold higher in the hypercholesterolemic rats of group 3 than in the hyperglycemic rats of group 1.
CONCLUSIONS: Acquisition of non-nodular glomerular sclerosis and tubulointerstitial disease is dependent on lipoxidation stress in rats with type II diabetes. On the other hand, in the absence of hypercholesterolemia, prolonged glycoxidation stress does not appear to be uniquely nephrotoxic.

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 10620191     DOI: 10.1046/j.1523-1755.2000.00814.x

Source DB:  PubMed          Journal:  Kidney Int        ISSN: 0085-2538            Impact factor:   10.612


  15 in total

Review 1.  Role of triglyceride-rich lipoproteins in diabetic nephropathy.

Authors:  John C Rutledge; Kit F Ng; Hnin H Aung; Dennis W Wilson
Journal:  Nat Rev Nephrol       Date:  2010-05-04       Impact factor: 28.314

Review 2.  Dyslipoproteinemia and impairment of renal function in diabetic kidney disease: an analysis of animal studies, observational studies, and clinical trials.

Authors:  Chi-Chih Hung; Jer-Chia Tsai; Hung-Tien Kuo; Jer-Ming Chang; Shang-Jyh Hwang; Hung-Chun Chen
Journal:  Rev Diabet Stud       Date:  2013-08-10

3.  Establishment and Validation of a Nomogram Model for Prediction of Diabetic Nephropathy in Type 2 Diabetic Patients with Proteinuria.

Authors:  Dong-Mei Zhou; Jing Wei; Ting-Ting Zhang; Feng-Jie Shen; Jin-Kui Yang
Journal:  Diabetes Metab Syndr Obes       Date:  2022-04-08       Impact factor: 3.168

4.  Vancomycin-Associated Nephrotoxicity: The Obesity Factor.

Authors:  Stephen W Davies; Jimmy T Efird; Christopher A Guidry; Zachary C Dietch; Rhett N Willis; Puja M Shah; Sara A Hennessy; Robert G Sawyer
Journal:  Surg Infect (Larchmt)       Date:  2015-09-01       Impact factor: 2.150

5.  Renal fat fraction and diffusion tensor imaging in patients with early-stage diabetic nephropathy.

Authors:  Yuan-Cheng Wang; Yinglian Feng; Chun-Qiang Lu; Shenghong Ju
Journal:  Eur Radiol       Date:  2018-02-15       Impact factor: 5.315

Review 6.  Mitochondrial dysfunction in diabetic kidney disease.

Authors:  Josephine M Forbes; David R Thorburn
Journal:  Nat Rev Nephrol       Date:  2018-02-19       Impact factor: 28.314

7.  LR-90 prevents dyslipidaemia and diabetic nephropathy in the Zucker diabetic fatty rat.

Authors:  J L Figarola; S Loera; Y Weng; N Shanmugam; R Natarajan; S Rahbar
Journal:  Diabetologia       Date:  2008-03-04       Impact factor: 10.122

8.  Smoking in diabetic nephropathy: sparks in the fuel tank?

Authors:  Vishal Arvind Chakkarwar
Journal:  World J Diabetes       Date:  2012-12-15

9.  Diabetic nephropathy amelioration by a low-dose sitagliptin in an animal model of type 2 diabetes (Zucker diabetic fatty rat).

Authors:  Cristina Mega; Edite Teixeira de Lemos; Helena Vala; Rosa Fernandes; Jorge Oliveira; Filipa Mascarenhas-Melo; Frederico Teixeira; Flávio Reis
Journal:  Exp Diabetes Res       Date:  2011-11-30

Review 10.  The selected traditional chinese medicinal formulas for treating diabetic nephropathy: perspective of modern science.

Authors:  Thing-Fong Tzeng; Shorong-Shii Liou; I-Min Liu
Journal:  J Tradit Complement Med       Date:  2013-07
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.